C16:0-Ceramide Signals Insulin Resistance

Slides:



Advertisements
Similar presentations
Lipids Introduction and classification
Advertisements

1 Metabolic Pathways for Lipids. Ketogenesis and Ketone Bodies. Fatty Acid Synthesis.
Carbohydrates, nucleotides, amino acids, now lipids Lipids exhibit diverse biological function –Energy storage –Biological membranes –Enzyme cofactors.
Metabolism of acylglycerols and sphingolipids Alice Skoumalová.
Chapter 17 Lipids 17.6 Sphingolipids.
COMPLEX LIPIDS DENTAL BIOCHEMISTRY 2015 Lecture 18 Michael Lea.
METABOLISM OF LIPIDS: SYNTHESIS OF FATTY ACIDS
Normal And Abnormal Cardiac Muscle Metabolism
The ART of Lowering Ceramides
Exercise Promotes Healthy Aging of Skeletal Muscle
Ghrelin—a new player in glucose homeostasis?
Acne vulgaris: The metabolic syndrome of the pilosebaceous follicle
Insulin Release: Shedding Light on a Complex Matter
Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle
ERRγ—A New Player in β Cell Maturation
All roads lead to FoxO Cell Metabolism
Sugar Makes Fat by Talking to SCAP
Omega 3 Fatty Acids and GPR120
Sphingolipid Signaling in Metabolic Disorders
Fatty Acid-Induced T Cell Loss Greases Liver Carcinogenesis
Volume 20, Issue 4, Pages (October 2014)
Macrophage Metabolism Shapes Angiogenesis in Tumors
More Chores for TOR: De Novo Ceramide Synthesis
Gal3 Links Inflammation and Insulin Resistance
Volume 11, Issue 5, Pages (May 2010)
Endothelial Cells Get β-ox-ed In to Support Lymphangiogenesis
Coming up for air: HIF-1 and mitochondrial oxygen consumption
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk  Jennifer H. Stern, Joseph M. Rutkowski,
Guido T. Bommer, Ormond A. MacDougald  Cell Metabolism 
Life Is Short, if Sweet Cell Metabolism
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Autophagy: A Sweet Process in Diabetes
Metabolomics and Metabolic Diseases: Where Do We Stand?
Volume 58, Issue 1, Pages (July 2000)
Selective Insulin and Leptin Resistance in Metabolic Disorders
Silencing Insulin Resistance through SIRT1
Estrogen Receptors and the Metabolic Network
Volume 11, Issue 3, Pages (March 2010)
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
Conserved Metabolic Regulatory Functions of Sirtuins
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
Cell Membranes: The Lipid Perspective
Pierre Theurey, Jennifer Rieusset  Trends in Endocrinology & Metabolism 
Insulin Action under Arrestin
A Ceramide-Centric View of Insulin Resistance
Varman T. Samuel, Gerald I. Shulman  Cell Metabolism 
Dietary Fat Inflames CD4+ T Cell Memory in Obesity
Vladimir Lizunov, Petr Chlanda, Mary Kraft, Joshua Zimmerberg 
Mario Cortese, Charles Sinclair, Bali Pulendran  Cell Metabolism 
Modulating Cholesterol Homeostasis to Build a Better T Cell
What Ignites UCP1? Cell Metabolism
Volume 14, Issue 2, Pages (August 2011)
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Protein Tyrosine Phosphatase 1B
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Sestrins Orchestrate Cellular Metabolism to Attenuate Aging
Lipid Metabolism Greases the Stem Cell Engine
Ann Marie Schmidt, Kathryn J. Moore  Cell Metabolism 
Treating Diabetes by Blocking a Vascular Growth Factor
Volume 104, Issue 4, Pages (February 2001)
Collecting new targets in MODY
Lipid Sensing and Insulin Resistance in the Brain
Paradoxical Effects of Sphingosine-1-Phosphate
The Insulin Receptor Talks to Glucagon?
Of Fat, β Cells, and Diabetes
Of Mice and Men: Not ExAKTly the Same?
Sugar Makes Fat by Talking to SCAP
Zuzana Tothova, D. Gary Gilliland  Cell Stem Cell 
Presentation transcript:

C16:0-Ceramide Signals Insulin Resistance Timothy Hla, Richard Kolesnick  Cell Metabolism  Volume 20, Issue 5, Pages 703-705 (November 2014) DOI: 10.1016/j.cmet.2014.10.017 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Impact of High-Fat Diet-Induced C16:0-Ceramide on Metabolic Dysregulation Sphingolipid synthesis begins with condensation of palmitoyl-CoA with serine forming 3-ketosphinganine, which is reduced to dihydrosphingosine (a.k.a. sphinganine) and thereafter acylated to dihydroceramide. Further reduction of the sphingoid base sphinganine backbone by formation of a trans-double bond yields ceramide, a central molecule in sphingolipid metabolism. Transfer of a phosphocholine headgroup from phosphatidylcholine to ceramide yields sphingomyelin, the most abundant mammalian sphingolipid, concentrated in the external plasma membrane, while glycosylation in Golgi begins the formation of a plethora of glycosphingolipids with complex carbohydrate headgroups. Alternately, ceramide deacylation by ceramidase frees up sphingosine for compartmentalized phosphorylation yielding sphingosine 1-phosphate. In the context of insulin resistance, high-fat diet selectively upregulates expression of CerS6, the C16:0-ceramide synthetic enzyme, and concomitantly provides increased amounts of the CerS6 substrate palmitate, enhancing C16:0-ceramide production. C16:0-ceramide induces insulin resistance by antagonizing insulin receptor (IR)-stimulated PI3K/Akt signaling, which attenuates glucose metabolism. In addition, Akt normally stimulates lipid metabolism by SREBP-dependent mechanisms, which would presumably be inhibited, although not directly investigated in the current manuscripts. C16:0-ceramide also appears to directly inhibit mitochondrial electron transport, by an as-yet-unknown mechanism, thereby indirectly suppressing β-oxidation. Inhibition of β-oxidation reduces fatty acid disposal, promoting accumulation of excessive TG in lipid droplets. Cell Metabolism 2014 20, 703-705DOI: (10.1016/j.cmet.2014.10.017) Copyright © 2014 Elsevier Inc. Terms and Conditions